1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Advancing Nanotechnology Research to Improve Diagnosis and Treatment Options (Highlighted Topic) is sponsored by National Institutes of Health (NIH). This NIH Highlighted Topic encourages the use of nanotechnology approaches, with a particular focus on extracellular vesicles (EVs), to promote transformative discoveries in areas related to disease diagnosis and treatment.
This topic is aimed at developing improved nanotools for early disease detection as well as therapeutics and drug delivery. While not a direct NOFO, it indicates an area of high interest for investigator-initiated applications to NIH, potentially involving collaboration with developing country scientists if the research context aligns with global health priorities.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: University researchers are eligible to apply through appropriate NIH Parent Funding Announcements. Specific eligibility would be determined by the chosen parent announcement. Confirm the full requirements in the official notice before applying.
Applications for Advancing Nanotechnology Research to Improve Diagnosis and Treatment Options (Highlighted Topic) are due March 10, 2028. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Advancing Nanotechnology Research to Improve Diagnosis and Treatment Options (Highlighted Topic) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article